Stay updated on Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision updated to v3.5.0 with new March 2026 dates, replacing the previous v3.4.3 revision.SummaryDifference0.3%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedAdministrative updates to the study record dates and metadata were added. No changes to core study details, eligibility criteria, or outcomes are evident.SummaryDifference0.2%

- Check54 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; there are no changes to core study content such as trial details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No user-visible changes to study content or page layout.SummaryDifference0.1%

- Check68 days agoChange DetectedGlossary UI is now displayed, and a new label 'Last Update Submitted that Met QC Criteria' appears, along with a revision note 'Revision: v3.4.0'. The prior 'Last Update Submitted that met QC Criteria' label and the 'No FEAR Act data' entry were removed or reformatted.SummaryDifference0.2%

Stay in the know with updates to Amivantamab SC in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab SC in Advanced Solid Malignancies Clinical Trial page.